1
|
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.
|
Nat Genet
|
2006
|
8.02
|
2
|
Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.
|
Infect Immun
|
2009
|
3.36
|
3
|
The Clostridium difficile spo0A gene is a persistence and transmission factor.
|
Infect Immun
|
2012
|
2.02
|
4
|
Structural insights into the molecular organization of the S-layer from Clostridium difficile.
|
Mol Microbiol
|
2009
|
1.71
|
5
|
Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues.
|
Infect Immun
|
2002
|
1.55
|
6
|
Clostridium difficile has two parallel and essential Sec secretion systems.
|
J Biol Chem
|
2011
|
1.50
|
7
|
Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1.
|
Infect Immun
|
2009
|
1.35
|
8
|
A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein.
|
Mol Microbiol
|
2009
|
1.30
|
9
|
Revised nomenclature of Clostridium difficile toxins and associated genes.
|
J Med Microbiol
|
2005
|
1.28
|
10
|
Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B.
|
Infect Immun
|
2011
|
1.24
|
11
|
Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress.
|
J Med Microbiol
|
2008
|
1.20
|
12
|
Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS.
|
J Mol Biol
|
2010
|
1.15
|
13
|
The Clostridium difficile cell wall protein CwpV is antigenically variable between strains, but exhibits conserved aggregation-promoting function.
|
PLoS Pathog
|
2011
|
1.11
|
14
|
Immunoreactive cell wall proteins of Clostridium difficile identified by human sera.
|
J Med Microbiol
|
2008
|
1.08
|
15
|
Roles of cysteine proteases Cwp84 and Cwp13 in biogenesis of the cell wall of Clostridium difficile.
|
J Bacteriol
|
2011
|
0.98
|
16
|
Chemical probes of surface layer biogenesis in Clostridium difficile.
|
ACS Chem Biol
|
2010
|
0.97
|
17
|
A proposed nomenclature for cell wall proteins of Clostridium difficile.
|
J Med Microbiol
|
2011
|
0.94
|
18
|
Transcriptional analysis of temporal gene expression in germinating Clostridium difficile 630 endospores.
|
PLoS One
|
2013
|
0.92
|
19
|
Functional characterization of OXA-57, a class D beta-lactamase from Burkholderia pseudomallei.
|
Antimicrob Agents Chemother
|
2005
|
0.88
|
20
|
CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen.
|
Cell Microbiol
|
2013
|
0.87
|
21
|
The spore-associated protein BclA1 affects the susceptibility of animals to colonization and infection by Clostridium difficile.
|
Mol Microbiol
|
2014
|
0.85
|
22
|
Clostridium difficile cell wall protein CwpV undergoes enzyme-independent intramolecular autoproteolysis.
|
J Biol Chem
|
2011
|
0.82
|
23
|
A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice.
|
Vaccine
|
2012
|
0.82
|
24
|
Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding.
|
Mol Immunol
|
2010
|
0.82
|
25
|
Clostridium difficile surface proteins are anchored to the cell wall using CWB2 motifs that recognise the anionic polymer PSII.
|
Mol Microbiol
|
2015
|
0.81
|
26
|
Novel inhibitors of surface layer processing in Clostridium difficile.
|
Bioorg Med Chem
|
2011
|
0.78
|
27
|
A multi-domain protein system based on the HC fragment of tetanus toxin for targeting DNA to neuronal cells.
|
J Drug Target
|
2003
|
0.78
|
28
|
Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment.
|
Vaccine
|
2003
|
0.77
|
29
|
Immunization does not interfere with uptake and transport by motor neurons of the binding fragment of tetanus toxin.
|
J Neurosci Res
|
2006
|
0.75
|